Latest Insider Transactions at Neoleukin Therapeutics, Inc. (NLTX)
This section provides a real-time view of insider transactions for Neoleukin Therapeutics, Inc. (NLTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Neoleukin Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Neoleukin Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 10
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
3,000
-0.22%
|
$42,000
$14.2 P/Share
|
|
Feb 05
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
600
-0.04%
|
$8,400
$14.0 P/Share
|
|
Feb 03
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
2,400
-0.17%
|
$31,200
$13.23 P/Share
|
|
Jul 07
2020
|
Baker Bros. Advisors LP Director |
BUY
Open market or private purchase
|
Indirect |
424,000
+9.3%
|
$6,360,000
$15.25 P/Share
|
|
Apr 02
2020
|
Redmile Group, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
9,834
-0.12%
|
$108,174
$11.56 P/Share
|
|
Apr 02
2020
|
Redmile Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
39,300
+0.48%
|
$432,300
$11.61 P/Share
|
|
Apr 01
2020
|
Redmile Group, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
9,834
-0.12%
|
$108,174
$11.47 P/Share
|
|
Apr 01
2020
|
Redmile Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
42,500
+0.53%
|
$467,500
$11.3 P/Share
|
|
Mar 31
2020
|
Redmile Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,000
+0.38%
|
$300,000
$10.45 P/Share
|
|
Mar 30
2020
|
Redmile Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
32,500
+0.41%
|
$325,000
$10.09 P/Share
|
|
Mar 27
2020
|
Redmile Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+1.26%
|
$450,000
$9.21 P/Share
|
|
Dec 20
2019
|
Baker Bros. Advisors LP Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
10,925,481
-77.92%
|
-
|
|
Dec 20
2019
|
Baker Bros. Advisors LP Director |
BUY
Open market or private purchase
|
Indirect |
3,017,542
+16.2%
|
$24,140,336
$8.4 P/Share
|
|
Aug 07
2019
|
Baker Bros. Advisors LP Director |
BUY
Open market or private purchase
|
Indirect |
289,725
+0.76%
|
$869,175
$3.04 P/Share
|
|
Aug 06
2019
|
Baker Bros. Advisors LP Director |
BUY
Open market or private purchase
|
Indirect |
81,800
+0.33%
|
$163,600
$2.84 P/Share
|
|
Aug 11
2015
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,283,366
-92.77%
|
$25,667,320
$20.74 P/Share
|
|
Aug 10
2015
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
231,455
-14.33%
|
$7,175,105
$31.66 P/Share
|
|
Dec 17
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,593
-0.12%
|
$11,151
$7.58 P/Share
|
|
Dec 16
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,507
-0.48%
|
$45,549
$7.63 P/Share
|
|
Dec 12
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,645
-0.27%
|
$25,515
$7.51 P/Share
|
|
Dec 11
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,355
-0.1%
|
$9,485
$7.5 P/Share
|
|
Dec 10
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,300
-0.1%
|
$9,100
$7.7 P/Share
|
|
Dec 09
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,000
-0.37%
|
$35,000
$7.73 P/Share
|
|
Dec 08
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,000
-0.15%
|
$14,000
$7.69 P/Share
|
|
Dec 05
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,200
-0.31%
|
$29,400
$7.78 P/Share
|
|
Dec 04
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,073
-0.73%
|
$70,511
$7.76 P/Share
|
|
Dec 03
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,627
-0.12%
|
$11,389
$7.75 P/Share
|
|
Dec 01
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,200
-0.09%
|
$8,400
$7.54 P/Share
|
|
Nov 26
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
500
-0.04%
|
$3,500
$7.6 P/Share
|
|
Nov 25
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,500
-0.11%
|
$10,500
$7.8 P/Share
|
|
Nov 24
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,000
-0.29%
|
$32,000
$8.02 P/Share
|
|
Nov 21
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,400
-0.17%
|
$19,200
$8.25 P/Share
|
|
Nov 20
2014
|
Johnson & Johnson > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,100
-0.22%
|
$24,800
$8.21 P/Share
|
|
Mar 12
2014
|
Johnson & Johnson > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,392,094
+50.0%
|
-
|